These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 36382758)

  • 1. Medical management of primary hyperparathyroidism.
    Bandeira F; de Moura Nóbrega J; de Oliveira LB; Bilezikian J
    Arch Endocrinol Metab; 2022 Nov; 66(5):689-693. PubMed ID: 36382758
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Efficacy and Safety of Medical and Surgical Therapy in Patients With Primary Hyperparathyroidism: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Ye Z; Silverberg SJ; Sreekanta A; Tong K; Wang Y; Chang Y; Zhang M; Guyatt G; Tangamornsuksun W; Zhang Y; Manja V; Bakaa L; Couban RJ; Brandi ML; Clarke B; Khan AA; Mannstadt M; Bilezikian JP
    J Bone Miner Res; 2022 Nov; 37(11):2351-2372. PubMed ID: 36053960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical presentation and management of patients with primary hyperparathyroidism in Italy.
    Saponaro F; Cetani F; Repaci A; Pagotto U; Cipriani C; Pepe J; Minisola S; Cipri C; Vescini F; Scillitani A; Salcuni A; Palmieri S; Eller-Vainicher C; Chiodini I; Madeo B; Kara E; Castellano E; Borretta G; Gianotti L; Romanelli F; Camozzi V; Faggiano A; Corbetta S; Cianferotti L; Brandi ML; De Feo ML; Palermo A; Vezzoli G; Maino F; Scalese M; Marcocci C
    J Endocrinol Invest; 2018 Nov; 41(11):1339-1348. PubMed ID: 29616419
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduction in parathyroid adenomas by cinacalcet therapy in patients with primary hyperparathyroidism.
    Minezaki M; Takashi Y; Ochi K; Mitsuoka R; Yamao Y; Kudo T; Kawanami D; Kobayashi K; Abe I
    J Bone Miner Metab; 2021 Jul; 39(4):583-588. PubMed ID: 33409573
    [TBL] [Abstract][Full Text] [Related]  

  • 5. What medical options should be considered for the treatment of primary hyperparathyroidism?
    Horwitz MJ
    Clin Endocrinol (Oxf); 2011 Nov; 75(5):592-5. PubMed ID: 21521319
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surgery for primary hyperparathyroidism.
    das Neves MC; Santos RO; Ohe MN
    Arch Endocrinol Metab; 2022 Nov; 66(5):678-688. PubMed ID: 36382757
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of cinacalcet hydrochloride in clinical management of primary hyperparathyroidism in multiple endocrine neoplasia type 1.
    Del Prete M; Marotta V; Ramundo V; Marciello F; Di Sarno A; Esposito R; Carratù AC; De Luca Di Roseto C; Di Somma C; Colao A; Faggiano A
    Minerva Endocrinol; 2013 Dec; 38(4):389-94. PubMed ID: 24285106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of Primary Hyperparathyroidism With Severe Hypercalcemia During the COVID-19 Pandemic.
    Alfadhli EM
    Clin Ther; 2021 Apr; 43(4):711-719. PubMed ID: 33752899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-surgical management of primary hyperparathyroidism.
    Cetani F; Saponaro F; Marcocci C
    Best Pract Res Clin Endocrinol Metab; 2018 Dec; 32(6):821-835. PubMed ID: 30665549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early biochemical response to parathyroidectomy for primary hyperparathyroidism and its predictive value for recurrent hypercalcemia and recurrent primary hyperparathyroidism.
    Ryder CY; Jarocki A; McNeely MM; Currey E; Miller BS; Cohen MS; Gauger PG; Hughes DT
    Surgery; 2021 Jan; 169(1):120-125. PubMed ID: 32768241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cinacalcet HCl reduces hypercalcemia in primary hyperparathyroidism across a wide spectrum of disease severity.
    Peacock M; Bilezikian JP; Bolognese MA; Borofsky M; Scumpia S; Sterling LR; Cheng S; Shoback D
    J Clin Endocrinol Metab; 2011 Jan; 96(1):E9-18. PubMed ID: 20943783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medical management of asymptomatic primary hyperparathyroidism: proceedings of the third international workshop.
    Khan A; Grey A; Shoback D
    J Clin Endocrinol Metab; 2009 Feb; 94(2):373-81. PubMed ID: 19193912
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cinacalcet HCl suppresses Cyclin D1 oncogene-derived parathyroid cell proliferation in a murine model for primary hyperparathyroidism.
    Imanishi Y; Kawata T; Kenko T; Wada M; Nagano N; Miki T; Arnold A; Inaba M
    Calcif Tissue Int; 2011 Jul; 89(1):29-35. PubMed ID: 21541686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Benefits and place of calcimimetics in the management of primary hyperparathyroidism.
    Meier C
    Ann Endocrinol (Paris); 2015 May; 76(2):163-4. PubMed ID: 25913524
    [No Abstract]   [Full Text] [Related]  

  • 15. Primary hyperparathyroidism.
    Muñoz-Torres M; García-Martín A
    Med Clin (Barc); 2018 Mar; 150(6):226-232. PubMed ID: 28992983
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of primary and renal hyperparathyroidism: guidelines from the German Association of Endocrine Surgeons (CAEK).
    Weber T; Dotzenrath C; Dralle H; Niederle B; Riss P; Holzer K; Kußmann J; Trupka A; Negele T; Kaderli R; Karakas E; Weber F; Rayes N; Zielke A; Hermann M; Wicke C; Ladurner R; Vorländer C; Waldmann J; Heizmann O; Wächter S; Schopf S; Timmermann W; Bartsch DK; Schmidmaier R; Luster M; Schmid KW; Ketteler M; Dierks C; Schabram P; Steinmüller T; Lorenz K
    Langenbecks Arch Surg; 2021 May; 406(3):571-585. PubMed ID: 33880642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cinacalcet-Associated Resolution of Primary Hyperparathyroidism in a Patient With Normal Kidney Function.
    Nguyen S; Gosmanova EO; Gosmanov AR
    J Investig Med High Impact Case Rep; 2020; 8():2324709620936836. PubMed ID: 32583691
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cinacalcet therapy in patients affected by primary hyperparathyroidism associated to Multiple Endocrine Neoplasia Syndrome type 1 (MEN1).
    Giusti F; Cianferotti L; Gronchi G; Cioppi F; Masi L; Faggiano A; Colao A; Ferolla P; Brandi ML
    Endocrine; 2016 Jun; 52(3):495-506. PubMed ID: 26224587
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical aspects of primary hyperparathyroidism: clinical manifestations, diagnosis, and therapy.
    Gasser RW
    Wien Med Wochenschr; 2013 Sep; 163(17-18):397-402. PubMed ID: 23990260
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Location of abnormal parathyroid glands: lessons from 810 parathyroidectomies.
    LoPinto M; Rubio GA; Khan ZF; Vaghaiwalla TM; Farra JC; Lew JI
    J Surg Res; 2017 Jan; 207():22-26. PubMed ID: 27979480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.